Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluation of platelet function in thrombocytopenia.

Mette Tiedemann Skipper1, Peter Rubak1, Jesper Stentoft2

  • 1a Centre for Haemophilia and Thrombosis , Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus , Denmark.

Platelets
|April 15, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Late effects in children and adolescents after treatment for cancer].

Ugeskrift for laeger·2026
Same author

Lipoprotein(a), interleukin-6 and cardiovascular risk in a primary prevention setting.

Atherosclerosis·2026
Same author

Pulmonary Function Deficit and Clinical Associations in Childhood Acute Lymphoblastic Leukaemia Survivors: A National Retrospective ALL-STAR Lungs Cohort Study.

Pediatric pulmonology·2026
Same author

Plasma proteomic signature of the human menstrual cycle.

Nature medicine·2026
Same author

Fibrotic disease co-occurrence and associated risk of subsequent organ failure: a nationwide matched cohort study.

Rheumatology (Oxford, England)·2026
Same author

Association between IL-6 and hs-CRP and Cardiovascular Risk in Clinically Relevant Subgroups.

European journal of preventive cardiology·2026

Whole blood aggregometry can now assess platelet function in thrombocytopenia. A novel adjusted impedance method revealed increased platelet activity in immune thrombocytopenia (ITP) patients, unlike cancer patients.

Area of Science:

  • Hematology
  • Clinical Pathology
  • Platelet Physiology

Background:

  • Whole blood aggregometry is a standard platelet function assay.
  • Its application in thrombocytopenia (low platelet count) has been limited.
  • Assessing platelet function in low-count conditions is clinically significant.

Purpose of the Study:

  • To explore platelet function in thrombocytopenia using a novel impedance aggregometry index.
  • To evaluate this method's association with flow cytometry assessments.
  • To investigate platelet function differences in immune thrombocytopenia (ITP) and hematological cancer patients.

Main Methods:

  • Collected blood from healthy volunteers, ITP patients, and cancer patients.
  • Analyzed platelet function using impedance aggregometry and flow cytometry.
Keywords:
Flow cytometryhematologic neoplasmimmune thrombocytopeniaplatelet aggregationplatelet function teststhrombocytopenia

Related Experiment Videos

  • Used various agonists (collagen, ADP, TRAP-6, ristocetin) for activation.

    • Main Results:

    • A novel platelet count-adjusted impedance aggregometry index was feasible.
    • ITP patients showed significantly increased platelet aggregation compared to healthy controls.
    • Cancer patients exhibited reduced platelet aggregation.
    • ITP patients had higher expression of bound fibrinogen and CD63 post-activation.

    Conclusions:

    • Impedance aggregometry adjusted for platelet count is a feasible method for assessing platelet function in thrombocytopenia.
    • This approach can differentiate platelet function in ITP versus cancer-related thrombocytopenia.
    • Findings highlight distinct platelet activation profiles in different thrombocytopenic conditions.